15-Deoxy-Δ12,14-prostaglandin J2
SIGMA/D8440 - ≥95% (HPLC), 1 mg/mL in methyl acetate
Synonym: 11-
CAS Number: 87893-55-8
Empirical Formula (Hill Notation): C20H28O3
Molecular Weight: 316.43
EC Number: 201-185-2
MDL Number: MFCD00065806
Linear Formula: C20H28O3
Product Type: Chemical
| assay | ≥95% (HPLC) |
| concentration | 1 mg/mL in methyl acetate |
| form | liquid |
| InChI | 1S/C20H28O3/c1-2-3-4-5-6- |
| InChI key | VHRUMKCAEVRUBK-GODQJPCRSA |
| Quality Level | 200 ![]() |
| shipped in | wet ice |
| SMILES string | CCCCCC=CC=C1/[C@@H](CC |
| storage temp. | −20°C |
| Application: | 15-Deoxy-Δ12,14-prostagla • to study its effect on lipid accumulation, viability/mitochondrial activity, and amount of vasculature in vascularized adipose tissue model • as a peroxisome proliferator-activated receptor (PPARγ) agonist to activate intestinal fatty acid binding protein (I-FABP)-PPARγ pathway • as a supplement in culture medium for induced neural stem/progenitor cells (NSPCs) differentiation |
| Biochem/physiol Actions: | 15-Deoxy-Δ12,14-prostagla |
| Biochem/physiol Actions: | Selective agonist to PPARγ (peroxisome proliferator-activated receptors). Inhibits the proliferation of cancer cell lines that express PPARγ and cyclooxygenase-2 (COX-2). |
| General description: | 15-Deoxy-Δ12,14-prostagla |
| Symbol | ![]() GHS02,GHS07 |
| Signal word | Danger |
| Hazard statements | H225 - H319 - H336 |
| Precautionary statements | P210 - P305 + P351 + P338 |
| Hazard Codes | F,Xi |
| Risk Statements | 11-36-66-67 |
| Safety Statements | 16-26-29-33 |
| RIDADR | UN1231 - class 3 - PG 2 - Methyl acetate, solution |
| WGK Germany | WGK 2 |
| Flash Point(F) | 15.8 °F - closed cup |
| Flash Point(C) | -9 °C - closed cup |
| Supplemental Hazard Statements | EUH066 |
| Purity | ≥95% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352211 |



